NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics
(www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has
completed the acquisition of Bestewil Holding B.V. and its subsidiary, Virosome
Biologicals B.V., from Norwood Immunology Limited (LSE:NIM) as per the terms of
the LOI described in the form 8-k filed on March 5, 2009.
The Mymetics Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=5478
Safe Harbor Forward-Looking Statements: Statements contained in this release
that are not strictly historical are "forward-looking statements". Such
forward-looking statements are sometimes identified by words such as "intends",
"anticipates", "believes", "expects" and "hopes". The forward-looking
statements are made based on information available as of the date hereof, and
the Company assumes no obligation to update such forward-looking statements.
Editors and investors are cautioned that such forward-looking statements
involve risks and uncertainties that could cause the Company's actual results
to differ materially from those in these forward-looking statements. Such risks
and uncertainties include but are not limited to demand for the Company's
products and services, our ability to continue to develop markets, general
economic conditions, our ability to secure additional financing for the Company
and other factors that may be more fully described in reports to shareholders
and periodic filings with the Securities and Exchange Commission.
CONTACT: Mymetics Corporation
North America
Anthony Jessop, Senior Vice President
1 303 800 6606
anthony.jessop@mymetics.com
Switzerland
Mr. Ernest Luebke, Chief Financial Officer
41 22 363 1310
Ernest.luebke@mymetics.ch
Mymetics Corporation Completes Important Acquisition
| Source: Mymetics Corporation